N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial

Overview of attention for article published in Critical Care, October 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 59,872 followers.

N-acetylcysteine + deferoxamine for pts with prolonged hypotension does not decrease acute kidney injury incidence: https://t.co/seFm41J8Fm

RT @Crit_Care: N-acetylcysteine plus deferoxamine for patients with prolonged #hypotension does not decrease #AKI incidence https://t.co/jg…

RT @Crit_Care: N-acetylcysteine plus deferoxamine for patients with prolonged #hypotension does not decrease #AKI incidence https://t.co/jg…

RT @Crit_Care: N-acetylcysteine plus deferoxamine for patients with prolonged #hypotension does not decrease #AKI incidence https://t.co/jg…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.